World
Tobacco-Based Covid Vaccine May Start Clinical Trials in Weeks
- Vaccine developed by Lucky Strike maker uses tobacco plants
- Tobacco plants provide way to produce vaccines more quickly
A tobacco plantation.
Photographer: Ty Wright/Bloomberg
This article is for subscribers only.
Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.
An experimental Covid-19 vaccine that’s produced in tobacco plants may start clinical trials within weeks as the race for immunization intensifies.